Haemophilia: Vol 24, No 5

I consent to Wiley Online Library’s Terms of Use and processing of my personal data as disclosed in Wiley’s Privacy Policy.I consent to my personal information being transferred outside of the People’s Republic of China as laid out in Wiley’s Privacy Policy.*(Optional) I consent to special offers, newsletter & promotions from Wiley. See Privacy Policy for more details.

Tools

Submit an article

Haemophilia

Journal list menu

Tools

Follow journal

Haemophilia: Volume 24, Issue 5

Download PDFs

ISSUE INFORMATION

Issue Information

REVIEW ARTICLES

Recommendations on multidisciplinary management of elective surgery in people with haemophilia

Clinical relevance of 3D gait analysis in patients with haemophilia

Review of molecular mechanisms at distal Xq28 leading to balanced or unbalanced genomic rearrangements and their phenotypic impacts on hemophilia

ORIGINAL ARTICLES

Clinical haemophilia

Desmopressin in non-severe haemophilia A: Test-response and clinical outcomes in a single Canadian centre review

Rate and appropriateness of polypharmacy in older patients with hemophilia compared with age-matched controls

BAY 94-9027, a PEGylated recombinant factor VIII, exhibits a prolonged half-life and higher area under the curve in patients with severe haemophilia A: Comprehensive pharmacokinetic assessment from clinical studies

Effectiveness of a comprehensive educational programme for Accredited Social Health Activists (ASHAs) to identify individuals in the Udupi district with bleeding disorders: A community-based survey

Risk factors for cardiovascular disease in children and young adults with haemophilia

Value of prophylaxis vs on-demand treatment: Application of a value framework in hemophilia

Pain assessment and management in haemophilia: A survey among Italian patients and specialist physicians

Rare bleeding disorders

Congenital coagulation factor X deficiency: Genetic analysis of five patients and functional characterization of mutant factor X proteins

Musculoskeletal

Clinical outcomes and patient satisfaction following total hip and knee arthroplasty in patients with inherited bleeding disorders: A 20-year single-surgeon cohort

Clinical and radiologic results after open-wedge high tibial osteotomy in haemophilic knee arthropathy with varus deformity

Impact of target joint and FVIII inhibitor οn bone properties in children with haemophilia A: A peripheral quantitative computed tomography study

Laboratory science

Distinguishing lupus anticoagulants from factor VIII inhibitors in haemophilic and non-haemophilic patients

Evaluating the thrombin generation profiles of four different rFVIII products in FVIII-deficient plasma using FIXa and FXIa activation

Factor VIII activity of BAY 94-9027 is accurately measured with most commonly used assays: Results from an international laboratory study

ISSUE INFORMATION

Instructions for Authors

REVIEW ARTICLE

Long-term outcomes from prophylactic or episodic treatment of haemophilia A: A systematic review

ORIGINAL ARTICLES

Clinical haemophilia

Abnormal coagulation and enhanced fibrinolysis due to lysinuric protein intolerance associates with bleeds and renal impairment

Real-world comparative analysis of bleeding complications and health-related quality of life in patients with haemophilia A and haemophilia B

The Japanese Immune Tolerance Induction (J-ITI) study in haemophilia patients with inhibitor: Outcomes and successful predictors of ITI treatment

Improvement in clinical outcomes and replacement factor VIII use in patients with haemophilia A after factor VIII pharmacokinetic-guided prophylaxis based on Bayesian models with myPKFiT®

Emotional distress in haemophilia: Factors associated with the presence of anxiety and depression symptoms among adults

Laboratory science

In silico and in vitro immunogenicity assessment of B-domain-modified recombinant factor VIII molecules

Potency estimates for recombinant factor IX in the one-stage clotting assay are influenced by more than just the choice of activated partial thromboplastin time reagent

ONLINE LETTERS

LETTERS TO THE EDITOR

Positioning extended half-life concentrates for future use: a practical proposal

The sudden and unexpected appearance of inhibitors in a previously treated severe haemophilia B patient after the switch to albutrepenonacog alpha

Application of optimized nursing process to perioperative patients with haemophilic pseudotumours

UK Haemophilia Centre Doctors’ Organisation guidance on the use of extended-half-life coagulation factor concentrates in routine clinical practice: Report of a meeting on their adoption by Belgian haemophilia treaters

Perioperative haemostasis in children with haemophilia and inhibitors during central venous catheter surgery: The Karolinska model

Retrospective review of Acquired Haemophilia A from the largest Canadian Haemophilia treatment centre

Efficacy and safety of low-dose prophylaxis of highly purified plasma-derived factor VIII concentrate produced by the National Blood Centre, Thai Red Cross Society

Sign up for email alerts

Tools

More from this journal

Improvement in clinical outcomes and replacement factor VIII use in patients with haemophilia A after factor VIII pharmacokinetic-guided prophylaxis based on Bayesian models with myPKFiT^®